Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
(iii) median duration on first- and (iv) second-line GLP-1RA therapy
I spend about $300 a month on my medications
Intellectual-property cliffs loom, with liraglutide generics already approved and semaglutide patents due to face challenges by 2027
Access and Reimbursement Hurdles Although many regulators approve innovative therapies, reimbursement policies vary widely across countries
These may include non-GLP-1 weight-management medications (such as phentermine-topiramate or bupropion-naltrexone), referral to bariatric surgery evaluation, or structured lifestyle programs without medication
Having a trusted resource for ongoing education makes you a better partner in your own care
